Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience.

Chantel CacciottiJungwhan ChoiSanda AlexandrescuMary Ann ZimmermanTabitha M CooneyChristine ChordasJessica ClymerSusan ChiKee Kiat Yeo

Published in: Journal of neuro-oncology (2020)

Immune checkpoint inhibition was relatively well tolerated in a cohort of pediatric patients spanning several CNS tumor diagnoses. Results from prospective clinical trials will be critical to inform clinical decisions.

Keyphrases

clinical trial
blood brain barrier
randomized controlled trial
open label
double blind